Assessing Phreesia: Insights From 7 Financial Analysts

Loading...
Loading...

7 analysts have expressed a variety of opinions on Phreesia PHR over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 4 0 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 1 1 0 0 0
3M Ago 1 3 0 0 0

Analysts have set 12-month price targets for Phreesia, revealing an average target of $29.29, a high estimate of $35.00, and a low estimate of $25.00. A 21.37% drop is evident in the current average compared to the previous average price target of $37.25.

Investigating Analyst Ratings: An Elaborate Study

The standing of Phreesia among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Jailendra Singh Truist Securities Announces Buy $35.00 -
Ryan MacDonald Needham Maintains Buy $29.00 -
Stephanie Davis Barclays Announces Overweight $29.00 -
John Ransom Raymond James Lowers Outperform $25.00 $30.00
Scott Schoenhaus Keybanc Lowers Overweight $30.00 $40.00
Joe Goodwin JMP Securities Lowers Market Outperform $28.00 $39.00
Ryan MacDonald Needham Lowers Buy $29.00 $40.00

Key Insights:

Loading...
Loading...
  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Phreesia. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Phreesia compared to the broader market.
  • Price Targets: Understanding forecasts, analysts offer estimates for Phreesia's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Phreesia's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Phreesia analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Delving into Phreesia's Background

Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.

A Deep Dive into Phreesia's Financials

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Positive Revenue Trend: Examining Phreesia's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.33% as of 31 October, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Phreesia's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -34.86% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Phreesia's ROE excels beyond industry benchmarks, reaching -12.49%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Phreesia's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -8.93%, the company may face hurdles in achieving optimal financial performance.

Debt Management: With a below-average debt-to-equity ratio of 0.05, Phreesia adopts a prudent financial strategy, indicating a balanced approach to debt management.

The Basics of Analyst Ratings

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...